Treating bipolar depression.
Shelton
Richard C
RC
Vanderbilt University School of Medicine, Nashville, TN, USA.
D000085:Acetates / Q000627:therapeutic use; D000339:Affect / Q000187:drug effects*; D000588:Amines; D000927:Anticonvulsants / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology*; D002220:Carbamazepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids; D005632:Fructose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077206:Gabapentin; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use; D000077213:Lamotrigine; D018020:Lithium Compounds / Q000627:therapeutic use; D009557:Nipecotic Acids / Q000627:therapeutic use; D000077152:Olanzapine; D000078330:Oxcarbazepine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078308:Tiagabine; D000077236:Topiramate; D016896:Treatment Outcome; D014227:Triazines / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use; D000078305:Zonisamide; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D014150:Antipsychotic Agents; D003509:Cyclohexanecarboxylic Acids; D007555:Isoxazoles; D018020:Lithium Compounds; D009557:Nipecotic Acids; D014227:Triazines; D000077236:Topiramate; D001569:Benzodiazepines; D005632:Fructose; D002220:Carbamazepine; D010890:Pirenzepine; D000078305:Zonisamide; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D000077206:Gabapentin; D000077152:Olanzapine; D000077213:Lamotrigine; D000078330:Oxcarbazepine; D000078308:Tiagabine